<DOC>
	<DOCNO>NCT01351545</DOCNO>
	<brief_summary>This study access distribution protocol unlicensed cryopreserved cord blood unit ( CBUs ) pediatric adult patient hematologic malignancy indication .</brief_summary>
	<brief_title>A Multicenter Access Distribution Protocol Unlicensed Cryopreserved Cord Blood Units ( CBUs )</brief_title>
	<detailed_description>Principal Investigators : The principal investigator ( PIs ) transplant physician participate U.S. transplant center . Study Design : This study access distribution protocol unlicensed cryopreserved cord blood unit ( CBUs ) pediatric adult patient hematologic malignancy indication . Primary Objective : The primary objective study examine incidence neutrophil recovery â‰¥500/mm3 cord blood transplantation multi-institution set use CBUs Food Drug Administration ( FDA ) license . Secondary Objectives : In patient receive non-licensed CBU : - Assess incidence transmission infection - Assess incidence serious infusion reaction - Determine 1 year overall survival cord blood transplantation - Assess cumulative incidence acute graft vs. host disease ( GVHD ) grade II IV grade III IV - Assess cumulative incidence chronic GVHD - Determine platelet engraftment &gt; 20,000 mcL &gt; 50,000 mcL</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<criteria>Disorders affect hematopoietic system inherit , acquire , result myeloablative treatment Signed informed consent ( sign assent , applicable ) obtain prior study enrollment Pediatric adult patient age Patients receive license CBUs Cord blood transplant recipients international transplant center Patients enrol another IND protocol access unlicensed CBU ( ) Patients whose select unlicensed CBU ( ) minimally manipulate</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>